<DOC>
	<DOCNO>NCT00124930</DOCNO>
	<brief_summary>The purpose study compare efficacy safety Haldol ( haloperidol ) olanzapine control chronic nausea advance cancer patient fail first line antiemetic therapy .</brief_summary>
	<brief_title>Study Comparing Olanzapine With Haloperidol Relief Nausea Vomiting Patients With Advanced Cancer</brief_title>
	<detailed_description>The purpose study compare efficacy safety haloperidol olanzapine control chronic nausea advance cancer patient fail first line antiemetic therapy .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>&gt; 18 year age Significant nausea/vomiting Failed maxeran domperidone Underlying treatment cause fail Adequate cognitive function Communicates well Partial/complete bowel obstruction Currently take Haldol olanzapine Has drug induce extrapyramidal symptom Parkinson 's disease Undergoing chemotherapy radiotherapy ( RT ) brain , abdomen , stomach esophagus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>olanzapine</keyword>
	<keyword>haldol</keyword>
	<keyword>cancer</keyword>
	<keyword>nausea</keyword>
	<keyword>second line treatment</keyword>
	<keyword>refractory nausea</keyword>
</DOC>